Advanced search
Publication Cover
Journal of Asthma Volume 46, 2009 - Issue 5
Submit an article Journal homepage
248
Views
20
CrossRef citations to date
0
Altmetric
CASE REPORT

Resolution of Corticosteroid-Induced Diabetes in Allergic Bronchopulmonary Aspergillosis with Omalizumab Therapy: A Novel Approach

Inderpal Randhawa UC Irvine Department of Pediatrics, Miller Children's Hospital, Long Beach, California, U.S.A.
, M.D.,
Terry Chin UC Irvine Department of Pediatrics, Miller Children's Hospital, Long Beach, California, U.S.A.
, M.D., Ph.D. &
Eliezer Nussbaum UC Irvine Department of Pediatrics, Miller Children's Hospital, Long Beach, California, U.S.A.
, M.D.
Pages 445-447 | Published online: 21 Jul 2009

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

K Suresh Babu, Riccardo Polosa & Jaymin B Morjaria. (2013) Anti-IgE – emerging opportunities for Omalizumab. Expert Opinion on Biological Therapy 13:5, pages 765-777.
Read now
Robert Y. Lin, Sonali Sethi & Geeta A. Bhargave. (2010) Measured Immunoglobulin E in Allergic Bronchopulmonary Aspergillosis Treated With Omalizumab. Journal of Asthma 47:8, pages 942-945.
Read now

Articles from other publishers (18)

Katsuyoshi Tomomatsu, Hirotaka Yasuba, Takashi Ishiguro, Shiro Imokawa, Johsuke Hara, Seiko Soeda, Norihiro Harada, Naomi Tsurikisawa, Naohiro Oda, Shigeki Katoh, Takanori Numata, Yasuteru Sugino, Mitsuhiro Yamada, Mitsuhiro Kamimura, Takeshi Terashima, Naoki Okada, Jun Tanaka, Tsuyoshi Oguma & Koichiro Asano. (2023) Real-world efficacy of anti-IL-5 treatment in patients with allergic bronchopulmonary aspergillosis. Scientific Reports 13:1.
Crossref
Meiling Jin, Jo A. Douglass, J. Stuart Elborn, Ritesh Agarwal, William J. Calhoun, Slawomir Lazarewicz, Xavier Jaumont & Meng Yan. (2023) Omalizumab in Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis. The Journal of Allergy and Clinical Immunology: In Practice 11:3, pages 896-905.
Crossref
Sara Manti, Alessandro Giallongo, Giuseppe Fabio Parisi, Maria Papale, Enza Mulè, Donatella Aloisio, Novella Rotolo & Salvatore Leonardi. (2022) Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review. European Respiratory Review 31:165, pages 220011.
Crossref
Roberto Bernardini, Gaia Toschi Vespasiani & Arianna Giannetti. (2022) An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics. Medicina 58:5, pages 625.
Crossref
Madeline G. Tompkins & Rebecca Pettit. (2021) Beyond the Guidelines: Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis. Annals of Pharmacotherapy 56:2, pages 181-192.
Crossref
Rahul ShrimankerXue Ning Choo & Ian D. Pavord. (2017) A new approach to the classification and management of airways diseases: identification of treatable traits. Clinical Science 131:10, pages 1027-1043.
Crossref
Raphaële Nové‐Josserand, Soazic Grard, Lila Auzou, Philippe Reix, Marlène Murris‐Espin, François Brémont, Benyebka Mammar, Laurent Mely, Dominique Hubert, Isabelle Durieu & Pierre‐Régis Burgel. (2016) Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients. Pediatric Pulmonology 52:2, pages 190-197.
Crossref
Jian-Xiong Li, Li-Chao Fan, Man-Hui Li, Wei-Jun Cao & Jin-Fu Xu. (2017) Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature. Respiratory Medicine 122, pages 33-42.
Crossref
Tetsuya Homma, Masatsugu Kurokawa, Satoshi Matsukura, Munehiro Yamaguchi & Mitsuru Adachi. (2016) Anti-IgE therapy for allergic bronchopulmonary aspergillosis. Journal of Microbiology, Immunology and Infection 49:3, pages 459-463.
Crossref
Sylvia Lehmann, Claus Pfannenstiel, Frank Friedrichs, Kristina Kröger, Norbert Wagner & Klaus Tenbrock. (2014) Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Therapeutic Advances in Respiratory Disease 8:5, pages 141-149.
Crossref
Kalliopi Tanou, Elias Zintzaras & Athanasios G. Kaditis. (2014) Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: A synthesis of published evidence. Pediatric Pulmonology 49:5, pages 503-507.
Crossref
Daniel Peckham & Paul Whitaker. (2013) Drug induced complications; can we do more?. Journal of Cystic Fibrosis 12:6, pages 547-558.
Crossref
R. Agarwal, A. Chakrabarti, A. Shah, D. Gupta, J. F. Meis, R. Guleria, R. Moss & D. W. Denning. (2013) Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clinical & Experimental Allergy 43:8, pages 850-873.
Crossref
Tse Wen Chang, Jiun-Bo Chen & Chia-Yu Chu. (2012) The pharmacological mechanisms of omalizumab in patients with very high IgE levels—Clues from studies on atopic dermatitis. Dermatologica Sinica 30:4, pages 147-153.
Crossref
J. Sanchez, R. Ramirez, S. Diez, S. Sus, A. Echenique, M. Olivares & R. Cardona. (2012) Omalizumab beyond asthma. Allergologia et Immunopathologia 40:5, pages 306-315.
Crossref
Ritesh Agarwal. (2011) Severe Asthma with Fungal Sensitization. Current Allergy and Asthma Reports 11:5, pages 403-413.
Crossref
P. Mulliez. (2010) Traitement de l’ABPA : une place pour le voriconazole et l’omalizumab ?. Revue des Maladies Respiratoires 27:7, pages 670-672.
Crossref
P. Germaud & A. Pipet. (2010) Aspergillose bronchopulmonaire allergique : nouvelles options thérapeutiques ?. Revue des Maladies Respiratoires 27:7, pages 784-785.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.